Targeting of Focal Adhesion Kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Ontology highlight
ABSTRACT: Targeting of Focal Adhesion Kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
PROVIDER: PRJNA975047 | ENA |
REPOSITORIES: ENA
ACCESS DATA